![Stephen Doberstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 30/06/2026
Dr. Stephen K.
Doberstein is an Independent Director at Invea Therapeutics, Inc., an Independent Director at Forte Biosciences, Inc. and a Principal at Kahiliholo Consulting LLC.
He is on the Board of Directors at Invea Therapeutics, Inc. and Forte Biosciences, Inc. Dr. Doberstein was previously employed as an Independent Director by Dicerna Pharmaceuticals, Inc., a Chief Scientific Fellow & Senior Vice President by Nektar Therapeutics, a Vice President-Research by XOMA Royalty Corp., a Vice President-Research by Five Prime Therapeutics, Inc., a Vice President-Research by Xencor, Inc., a Director-Pharmaceutical Target Research by Exelixis, Inc., and an Engineer by EIDP, Inc. He also served on the board at Parmedics, Inc. He received his undergraduate degree from the University of Delaware and a doctorate degree from The Johns Hopkins University School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 29/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| FORTE BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 12/05/2022 |
Kahiliholo Consulting LLC | Corporate Officer/Principal | 01/02/2020 |
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs | Direttore/Membro del Consiglio | 01/12/2024 |
| Società | Posizione | Fine |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 28/12/2021 |
| NEKTAR THERAPEUTICS | Direttore Tecnico/Scientifico/R&S | 01/03/2020 |
| FIVE PRIME THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/10/2008 |
| XENCOR, INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2004 |
| EXELIXIS, INC. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
EIDP, Inc.
 EIDP, Inc. Chemicals: AgriculturalProcess Industries Manufactures and sells seed & crop protection products | Process Industries |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forte Biosciences, Inc.
 Forte Biosciences, Inc. BiotechnologyHealth Technology Provides dermatological therapies and related services | Health Technology |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs | Health Technology |
Kahiliholo Consulting LLC |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
